Medtronic is the leading global healthcare technology company, boldly attacking the most challenging health problems facing humanity and united by our Mission to alleviate pain, restore health, and extend life for millions of people around the world. We are committed to delivering long-term, meaningful value to shareholders given our diversified business with leading market positions in growth markets, a robust product pipeline, solid free cash flow, strong balance sheet, and growing dividend.
-
78M+ Patients served
-
190+Active Clinical Trials
in FY24 -
$2.7B R&D investments
in FY24 -
$3.7B Dividends in FY24